IT Solutions
Data Integrity module
Feb 21 2018
LabWare has developed and launched a new data integrity module for its enterprise LIMS and ELN solution to help drug manufacturers conform to the FDA draft guidance on ‘Data Integrity and Compliance with CGMP’.
The new enhancement to LabWare LIMS & ELN ensures that companies are able to meet current and proposed regulatory guidance regarding the management of data in temporary memory. New and emerging data integrity standards put forth by the U.S. Food and Drug Administration (FDA), U.K. Medicines and Healthcare Products Regulatory Agency (MHRA), and World Health Organization (WHO), which would require the capture of temporary data in electronic records.
The new features are in addition to LabWare current solution that supports a GxP-compliant audit trail based on a full history of analytical testing, including:
Forced Save during manual result entry, to mitigate manipulation of values in temporary memory.
Disabling manual entry when data is captured directly from instrumentation
Forced reviews of Audit Trail entries when exceptions occur, such as result modification
Checksum generation and checking against data records, to detect manipulation.
Date time of data entry
Electronic Signature and mandatory reason for change
Digital Edition
International Labmate Buyers' Guide 2024/25
June 2024
Buyers' Guide featuring: Product Listings & Manufacturers Directory Chromatography Articles - Enhancing HPLC Field Service with fast-response, non-invasive flowmeters - Digital transformatio...
View all digital editions
Events
Jul 07 2024 Dublin, Ireland
Jul 20 2024 Denver, CO, USA
Jul 21 2024 Cape Town, South Africa
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia